Your browser doesn't support javascript.
loading
Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
Liang, Jie-Ying; Xi, Shao-Yan; Shao, Qiong; Yuan, Yun-Fei; Li, Bin-Kui; Zheng, Yun; Wang, De-Shen; Wu, Xiao-Jun; Ding, Pei-Rong; Chen, Gong; Li, Li-Ren; Wang, Feng-Hua; Wang, Zhi-Qiang; Pan, Zhi-Zhong; Xu, Rui-Hua; Li, Yu-Hong.
Afiliação
  • Liang JY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Xi SY; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Shao Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Yuan YF; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li BK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Zheng Y; Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wang DS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wu XJ; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Ding PR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chen G; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li LR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wang FH; Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wang ZQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Pan ZZ; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Xu RH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li YH; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Cancer Immunol Immunother ; 69(12): 2623-2634, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32601799
Various scoring systems have been proposed to predict the postoperative prognosis of colorectal liver metastasis (CRLM), including the clinical risk score (CRS), the immunoscore and so on. Recently, histopathological growth patterns (HGPs) have been recognized. However, the correlation between HGPs and the immunoscore, and their prognostic values in patients with CRLM after liver resection remain undetermined. In this study, HGPs were retrospectively evaluated in H&E-stained slides from 166 CRLM patients. The immunoscore was calculated according to the densities of immunostained CD3 + and CD8 + cells. A risk score combining HGPs, the immunoscore and the CRS was defined and divided patients into the low-, medium- and high-risk group. Our results showed that the densities of CD3 + and CD8 + cells were higher in the desmoplastic HGP (dHGP) group than in the non-dHGP group, and the proportion of high immunoscores was also higher in the dHGP group (51.9% vs. 33.0%, respectively, P = 0.020). Patients with the dHGP had significantly longer relapse-free survival (RFS) and overall survival (OS) than those with the non-HGP. The low-risk group showed significantly higher 2-year RFS and 5-year OS rates than the other two groups (RFS: 76.2%, 43.7% and 33.1%, respectively; P < 0.001; OS: 89.7%, 54.4% and 33.3%, respectively; P < 0.001). In conclusion, the dHGP correlates with relatively high immunoscores, predicting a favorable prognosis independent of the immunoscore and CRS. A novel risk score combining HGPs, the immunoscore and the CRS may be used for the stratification of CRLM patients' survival.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Hepatectomia / Fígado / Neoplasias Hepáticas / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Hepatectomia / Fígado / Neoplasias Hepáticas / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article